Lakefront Biotherapeutics (GLPGF) Prepaid Assets (2013 - 2026)

Lakefront Biotherapeutics (GLPGF) has reported Prepaid Assets for 14 consecutive years, with $4.8 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Prepaid Assets fell 85.52% year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 85.52% decrease from a year earlier, with the FY2025 full-year figure at $7.9 million, down 76.46% from the prior year.
• Prepaid Assets was $4.8 million for Q1 2026 at Lakefront Biotherapeutics, down from $8.2 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $23.8 billion in Q4 2022 and troughed at $4.8 million in Q1 2026.
• A 5-year average of $1.8 billion and a median of $17.1 million in 2023 frame the typical range for Prepaid Assets.
• The widest YoY moves for Prepaid Assets: up 156.46% in 2023, down 99.93% in 2023.
• Over 5 years, Prepaid Assets stood at $23.8 billion in 2022, then tumbled by 99.93% to $16.3 million in 2023, then jumped by 103.68% to $33.2 million in 2024, then plunged by 75.43% to $8.2 million in 2025, then slumped by 41.47% to $4.8 million in 2026.
• The last three Prepaid Assets figures came in at $4.8 million (Q1 2026), $8.2 million (Q4 2025), and $13.2 million (Q3 2025), per Business Quant data.